J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?

Journal of Nephrology
Nicolás Roberto RoblesGuido Grassi

Abstract

Aggressive reduction of blood pressure (BP) may increase cardiovascular events (the J-curve phenomenon) in certain populations. There is a high number of available studies of antihypertensive treatment that provide strong evidence for J-shaped relationships between both diastolic and systolic BP and main cardiovascular outcomes. Nonetheless, most available studies were observational, and randomized trials might not have or lost their statistical power in post-hoc analysis. Contrariwise, most of prospective trial to demonstrate the benefits of intensive blood pressure control were inconclusive. Therefore, further studies are still necessary in order to clarify this issue.

References

Mar 14, 1987·Lancet·J M CruickshankF J Zacharias
Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Oct 1, 1993·Hypertension·R D LangerT G Ganiats
Oct 8, 1999·Archives of Internal Medicine·G W SomesW B Applegate
Aug 25, 2001·Journal of Clinical Epidemiology·S SatishJ S Goodwin
Mar 20, 2002·Annals of Internal Medicine·Florent BoutitieUNKNOWN INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention
Jul 24, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Naoyuki HasebeUNKNOWN Angiographical Study in Angina with Hypertension Induced Insults (ASAHI) Investigators
Oct 16, 2003·Current Cardiology Reports·John Cruickshank
Jul 28, 2004·The American Journal of Cardiology·William B KannelJ Li
Nov 13, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN CAMELOT Investigators
May 23, 2007·Hypertension·Athanase D ProtogerouJacques Blacher
Sep 26, 2007·Archives of Internal Medicine·Robert H FagardYair Yodfat
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Oct 20, 2009·Journal of Hypertension·Giuseppe ManciaUNKNOWN European Society of Hypertension
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Jun 10, 2010·Hypertension·Toshio OgiharaUNKNOWN Valsartan in Elderly Isolated Systolic Hypertension Study Group
Aug 6, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiromi RakugiUNKNOWN JATOS Study Group
Sep 16, 2010·Current Vascular Pharmacology·Maciej BanachKrzysztof Narkiewicz
Sep 18, 2010·European Heart Journal·Sripal BangaloreUNKNOWN Treating to New Targets Steering Committee and Investigators
Nov 10, 2011·Hypertension·Johannes A N DorresteijnUNKNOWN Secondary Manifestations of Arterial Disease Study Group
Feb 22, 2012·Journal of Hypertension·Peter M OkinRichard B Devereux
Apr 2, 2013·The American Journal of Medicine·Michael A WeberKenneth Jamerson

❮ Previous
Next ❯

Citations

Jan 24, 2019·Journal of Nephrology·Roberto MinutoloUNKNOWN Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology
Nov 7, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lorenzo SignoriniGiovanni Gambaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Current Hypertension Reports
Maciej Banach, Wilbert S Aronow
Current Hypertension Reports
Jolanta MalyszkoMaciej Banach
The Journal of Clinical Hypertension
Nicolás Roberto RoblesGuido Grassi
© 2022 Meta ULC. All rights reserved